StockSelector.com
  Research, Select, & Monitor Sunday, August 25, 2019 4:28:52 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Five Prime Therapeutics Inc$5.56($.19)(3.30%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Five Prime Therapeutics Inc has an overall rank of 3808 out of 7130 stocks based on 8 positive rankings and 9 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $10.00 for Five Prime Therapeutics Inc using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Five Prime Therapeutics Inc is ranked 157.
Historic Revenue Growth
Five Prime Therapeutics Inc rank is 426
Debt-to-Equity
Five Prime Therapeutics Inc rank is 487
Highest Cash Growth
Five Prime Therapeutics Inc rank is 513
Low Put/Call
Five Prime Therapeutics Inc has a low Put/Call ratio of 0.29 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Five Prime Therapeutics Inc is ranked 788.
Price-to-Book
Five Prime Therapeutics Inc rank is 824
10 Day Gain
Five Prime Therapeutics Inc rank is 891
Estimated Revenue Growth
Five Prime Therapeutics Inc rank is 896
Negative Rankings
Negative Net Margin
Five Prime Therapeutics Inc rank is 202
90 Day Loss
Five Prime Therapeutics Inc rank is 298
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Five Prime Therapeutics Inc is ranked 411.
Price-to-Sales
Five Prime Therapeutics Inc rank is 480
Negative ROA
Five Prime Therapeutics Inc rank is 598
Negative ROE
Five Prime Therapeutics Inc rank is 615
Down EPS Surprise
Five Prime Therapeutics Inc missed the consensus earnings estimate when it last reported quarterly earnings.
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Five Prime Therapeutics Inc is ranked 810.
High vPut/Call
Five Prime Therapeutics Inc has a high Put/Call ratio of 0.44 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Five Prime Therapeutics Inc is ranked 2257.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.